Photon-counting computed tomography
Citation, DOI, disclosures and article data
At the time the article was created Bálint Botz had no recorded disclosures.
View Bálint Botz's current disclosuresAt the time the article was last revised Frank Gaillard had the following disclosures:
- Biogen Australia Pty Ltd, Investigator-Initiated Research Grant for CAD software in multiple sclerosis: finished Oct 2021 (past)
These were assessed during peer review and were determined to not be relevant to the changes that were made.
View Frank Gaillard's current disclosures- Photon-counting computed tomography (PCCT)
Photon-counting computed tomography (PCCT) is an emerging technology (c.2021) in CT that could represent the next major technological milestone in the field. Briefly, photon-counting CT uses energy-resolving detectors, thereby enabling scanning at multiple energies.
Physics
Current clinical CT systems rely on energy-integrating detectors (EID), which measure the total x-ray energy reaching the detector during the measurement period. The photon-counting detectors (PCD) in a photon-counting CT system count the exact number of incoming x-ray photons and also measure their energy individually. As a consequence, photon-counting detectors always obtain spectral information and can effectively filter out electronic noise unlike energy-integrating detectors, resulting in significantly improved signal-to-noise ratio 1,2.
Practical points
Photon-counting CT readily differentiates between tissue types and contrast agents much like spectral CT. In the future, photon-counting CT could offer higher signal-to-noise ratio, better spatial resolution, superior virtual non-contrast imaging, and spectral imaging data much like dual-energy CT currently does. It could reduce radiation exposure, reduce the amount of contrast agent needed, and lower the amount of CT artifacts. It could also make simultaneous imaging with multiple contrast agents (e.g. iodine, gadolinium, or gold nanoparticles) feasible. Unlike conventional CT, photon-counting CT can readily measure the exact concentration of materials within the voxel (e.g. calcium, iodine), resulting in improved accuracy of studies such as perfusion imaging, kidney stone characterization, or bone density measurements 2.
Initial technical challenges were primarily posed by cross-talk between the detector elements and the extremely fast detector readout required to separately count each incident x-ray photon 1,2. The first commercial photon-counting CT device was given US Food & Drug Administration (FDA) approval in 2021 3. Early clinical results demonstrate a substantial improvement in spatial resolution and reduction of noise compared to the existing state-of-the-art CT systems 4.
References
- 1. B. Theek, T. Nolte, D. Pantke, F. Schrank, F. Gremse, V. Schulz, F. Kiessling. Emerging methods in radiology. (2020) Der Radiologe. doi:10.1007/s00117-020-00696-0 - Pubmed
- 2. Martin J. Willemink, Mats Persson, Amir Pourmorteza, Norbert J. Pelc, Dominik Fleischmann. Photon-counting CT: Technical Principles and Clinical Prospects. (2018) Radiology. 289 (2): 293-312. doi:10.1148/radiol.2018172656 - Pubmed
- 3. U.S. Food & Drug Administration. September 2021 510(K) Clearances [website]. Available from: https://www.fda.gov/medical-devices/510k-clearances/september-2021-510k-clearances [Accessed 18 Nov 2021].
- 4. Rajendran K, Petersilka M, Henning A et al. First Clinical Photon-Counting Detector CT System: Technical Evaluation. Radiology. 2021;:212579. doi:10.1148/radiol.212579 - Pubmed
Incoming Links
Related articles: Imaging technology
- imaging technology
- imaging physics
- imaging in practice
-
x-rays
- x-ray physics
- x-ray in practice
- x-ray production
- x-ray tube
- filters
- automatic exposure control (AEC)
- beam collimators
- grids
- air gap technique
- cassette
- intensifying screen
- x-ray film
- image intensifier
- digital radiography
- digital image
- mammography
- x-ray artifacts
- radiation units
- radiation safety
- radiation detectors
- fluoroscopy
-
computed tomography (CT)
- CT physics
- CT in practice
- CT technology
- CT image reconstruction
- CT image quality
- CT dose
-
CT contrast media
-
iodinated contrast media
- agents
- water soluble
- water insoluble
- vicarious contrast material excretion
- iodinated contrast media adverse reactions
- agents
- non-iodinated contrast media
-
iodinated contrast media
-
CT artifacts
- patient-based artifacts
- physics-based artifacts
- hardware-based artifacts
- ring artifact
- tube arcing
- out of field artifact
- air bubble artifact
- helical and multichannel artifacts
- CT safety
- history of CT
-
MRI
- MRI physics
- MRI in practice
- MRI hardware
- signal processing
-
MRI pulse sequences (basics | abbreviations | parameters)
- T1 weighted image
- T2 weighted image
- proton density weighted image
- chemical exchange saturation transfer
- CSF flow studies
- diffusion weighted imaging (DWI)
- echo-planar pulse sequences
- fat-suppressed imaging sequences
- gradient echo sequences
- inversion recovery sequences
- metal artifact reduction sequence (MARS)
-
perfusion-weighted imaging
- techniques
- derived values
- saturation recovery sequences
- spin echo sequences
- spiral pulse sequences
- susceptibility-weighted imaging (SWI)
- T1 rho
- MR angiography (and venography)
-
MR spectroscopy (MRS)
- 2-hydroxyglutarate peak: resonates at 2.25 ppm
- alanine peak: resonates at 1.48 ppm
- choline peak: resonates at 3.2 ppm
- citrate peak: resonates at 2.6 ppm
- creatine peak: resonates at 3.0 ppm
- functional MRI (fMRI)
- gamma-aminobutyric acid (GABA) peak: resonates at 2.2-2.4 ppm
- glutamine-glutamate peak: resonates at 2.2-2.4 ppm
- Hunter's angle
- lactate peak: resonates at 1.3 ppm
- lipids peak: resonates at 1.3 ppm
- myoinositol peak: resonates at 3.5 ppm
- MR fingerprinting
- N-acetylaspartate (NAA) peak: resonates at 2.0 ppm
- propylene glycol peak: resonates at 1.13 ppm
-
MRI artifacts
- MRI hardware and room shielding
- MRI software
- patient and physiologic motion
- tissue heterogeneity and foreign bodies
- Fourier transform and Nyquist sampling theorem
- MRI contrast agents
- MRI safety
-
ultrasound
- ultrasound physics
-
transducers
- linear array
- convex array
- phased array
- frame averaging (frame persistence)
- ultrasound image resolution
- imaging modes and display
- pulse-echo imaging
- real-time imaging
-
Doppler imaging
- Doppler effect
- color Doppler
- power Doppler
- B flow
- color box
- Doppler angle
- pulse repetition frequency and scale
- wall filter
- color write priority
- packet size (dwell time)
- peak systolic velocity
- end-diastolic velocity
- resistive index
- pulsatility index
- Reynolds number
- panoramic imaging
- compound imaging
- harmonic imaging
- elastography
- scanning modes
- 2D ultrasound
- 3D ultrasound
- 4D ultrasound
- M-mode
-
ultrasound artifacts
- acoustic shadowing
- acoustic enhancement
- beam width artifact
- reverberation artifact
- ring down artifact
- mirror image artifact
- side lobe artifact
- speckle artifact
- speed displacement artifact
- refraction artifact
- multipath artifact
- anisotropy
- electrical interference artifact
- hardware-related artifacts
- Doppler artifacts
- aliasing
- tissue vibration
- spectral broadening
- blooming
- motion (flash) artifact
- twinkling artifact
- acoustic streaming
- biological effects of ultrasound
- history of ultrasound
-
nuclear medicine
- nuclear medicine physics
- detectors
- tissue to background ratio
-
radiopharmaceuticals
- fundamentals of radiopharmaceuticals
- radiopharmaceutical labeling
- radiopharmaceutical production
- nuclear reactor produced radionuclides
- cyclotron produced radionuclides
- radiation detection
- dosimetry
- specific agents
- carbon-11
- chromium-51
- fluorine agents
- gallium agents
- Ga-67 citrate
- Ga-68
- iodine agents
-
I-123
- I-123 iodide
- I-123 ioflupane (DaTSCAN)
- I-123 ortho-iodohippurate
- I-131
-
MIBG scans
- I-123 MIBG
- I-131 MIBG
-
I-123
- indium agents
- In-111 Octreoscan
- In-111 OncoScint
- In-111 Prostascint
- In-111 oxine labeled WBC
- krypton-81m
- nitrogen-13
- oxygen-15
- phosphorus-32
- selenium-75
-
technetium agents
- Tc-99m DMSA
- Tc-99m DTPA
- Tc-99m DTPA aerosol
- Tc-99m HMPAO
- Tc-99m HMPAO labeled WBC
- Tc-99m MAA
- Tc-99m MAG3
- Tc-99m MDP
- Tc-99m mercaptoacetyltriglycine
- Tc-99m pertechnetate
- Tc-99m labeled RBC
- Tc-99m sestamibi
- Tc-99m sulfur colloid
- Tc-99m sulfur colloid (oral)
- thallium-201 chloride
- xenon agents
- in vivo therapeutic agents
- pharmaceuticals used in nuclear medicine
-
emerging methods in medical imaging
- radiography
- phase-contrast imaging
- CT
- deep-learning reconstruction
- photon counting CT
- virtual non-contrast imaging
- ultrasound
- magnetomotive ultrasound (MMUS)
- superb microvascular imaging
- ultrafast Doppler imaging
- ultrasound localization microscopy
- MRI
- nuclear medicine
- total body PET system
- immuno-PET
- miscellaneous
- radiography